mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
2e-22 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-19 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.38 |
2e-19 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-18 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
3e-16 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-14 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-14 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-13 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
4e-13 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
8e-13 |